Kenneth Allen Myszkowski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kenneth Allen Myszkowski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kenneth Allen Myszkowski. Kenneth Allen Myszkowski is CFO in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) and Chief Financial Officer in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR).
Latest Insider Trading Transactions of Kenneth Allen Myszkowski
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 81.00 | 1,441 | 116,721 | 444,005 | 445.4 K to 444 K (-0.32 %) |
| Jan 12 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 81.02 | 11,597 | 939,589 | 445,446 | 457 K to 445.4 K (-2.54 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 72.63 | 25,166 | 1,827,807 | 457,043 | 482.2 K to 457 K (-5.22 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 71.77 | 4,359 | 312,845 | 482,209 | 486.6 K to 482.2 K (-0.90 %) |
| Jan 07 2021 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 70.75 | 1,100 | 77,825 | 486,568 | 487.7 K to 486.6 K (-0.23 %) |
| Nov 12 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 14.54 | 43,505 | 632,563 | 0 | |
| Nov 12 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 69.86 | 17,665 | 1,234,077 | 427,668 | 445.3 K to 427.7 K (-3.97 %) |
| Nov 12 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 69.04 | 25,840 | 1,783,994 | 445,333 | 471.2 K to 445.3 K (-5.48 %) |
| Nov 12 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 14.54 | 43,505 | 632,563 | 471,173 | 427.7 K to 471.2 K (+10.17 %) |
| Oct 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 6.15 | 29,166 | 179,371 | 43,505 | |
| Oct 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 54.04 | 29,166 | 1,576,131 | 427,668 | 456.8 K to 427.7 K (-6.38 %) |
| Oct 22 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 6.15 | 29,166 | 179,371 | 456,834 | 427.7 K to 456.8 K (+6.82 %) |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 6.15 | 10,834 | 66,629 | 72,671 | |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 7.75 | 12,116 | 93,899 | 83,505 | |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 14.54 | 6,495 | 94,437 | 95,621 | |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.19 | 2,000 | 10,380 | 102,116 | |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 9.90 | 12,000 | 118,800 | 104,116 | |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 6.15 | 10,834 | 66,629 | 427,668 | 416.8 K to 427.7 K (+2.60 %) |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 7.75 | 12,116 | 93,899 | 416,834 | 404.7 K to 416.8 K (+2.99 %) |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 14.54 | 6,495 | 94,437 | 404,718 | 398.2 K to 404.7 K (+1.63 %) |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.19 | 2,000 | 10,380 | 398,223 | 396.2 K to 398.2 K (+0.50 %) |
| Feb 27 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 9.90 | 12,000 | 118,800 | 396,223 | 384.2 K to 396.2 K (+3.12 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.19 | 33,351 | 173,092 | 116,116 | |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 52.13 | 3,450 | 179,849 | 384,223 | 387.7 K to 384.2 K (-0.89 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 51.11 | 10,680 | 545,855 | 387,673 | 398.4 K to 387.7 K (-2.68 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 49.98 | 2,800 | 139,944 | 398,353 | 401.2 K to 398.4 K (-0.70 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 49.07 | 10,554 | 517,885 | 401,153 | 411.7 K to 401.2 K (-2.56 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 47.93 | 6,432 | 308,286 | 411,707 | 418.1 K to 411.7 K (-1.54 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 47.07 | 6,397 | 301,107 | 418,139 | 424.5 K to 418.1 K (-1.51 %) |
| Jan 23 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.19 | 33,351 | 173,092 | 424,536 | 391.2 K to 424.5 K (+8.53 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 60.95 | 500 | 30,475 | 391,185 | 391.7 K to 391.2 K (-0.13 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 60.40 | 11,907 | 719,183 | 391,685 | 403.6 K to 391.7 K (-2.95 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 59.60 | 7,593 | 452,543 | 403,592 | 411.2 K to 403.6 K (-1.85 %) |
| Nov 07 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.19 | 12,649 | 65,648 | 149,467 | |
| Nov 07 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.19 | 12,649 | 65,648 | 326,185 | 313.5 K to 326.2 K (+4.03 %) |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 7.75 | 37,884 | 293,601 | 162,116 | |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 41.21 | 16,620 | 684,910 | 313,536 | 330.2 K to 313.5 K (-5.03 %) |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 40.56 | 21,264 | 862,468 | 330,156 | 351.4 K to 330.2 K (-6.05 %) |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 7.75 | 37,884 | 293,601 | 351,420 | 313.5 K to 351.4 K (+12.08 %) |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 7.75 | 37,884 | 293,601 | 162,116 | |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 41.21 | 16,620 | 684,910 | 313,536 | 330.2 K to 313.5 K (-5.03 %) |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 40.56 | 21,264 | 862,468 | 330,156 | 351.4 K to 330.2 K (-6.05 %) |
| Nov 01 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 7.75 | 37,884 | 293,601 | 351,420 | 313.5 K to 351.4 K (+12.08 %) |
| Jun 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.19 | 20,000 | 103,800 | 200,000 | |
| Jun 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 4.60 | 15,000 | 69,000 | 220,000 | |
| Jun 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.19 | 20,000 | 103,800 | 313,536 | 293.5 K to 313.5 K (+6.81 %) |
| Jun 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 4.60 | 15,000 | 69,000 | 293,536 | 278.5 K to 293.5 K (+5.39 %) |
| May 22 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 22.00 | 27,071 | 595,562 | 278,536 | 305.6 K to 278.5 K (-8.86 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.20 | 8,000 | 41,600 | 235,000 | |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 18.00 | 8,000 | 144,000 | 305,607 | 313.6 K to 305.6 K (-2.55 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.20 | 8,000 | 41,600 | 313,607 | 305.6 K to 313.6 K (+2.62 %) |
| Jan 18 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 14.55 | 81,875 | 1,191,281 | 305,607 | 387.5 K to 305.6 K (-21.13 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 11.98 | 8,333 | 99,829 | 387,482 | 395.8 K to 387.5 K (-2.11 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Grant | A | 0.00 | 85,000 | 0 | 395,815 | 310.8 K to 395.8 K (+27.35 %) |
| Sep 10 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 4.75 | 20,000 | 95,000 | 243,000 | |
| Sep 10 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.62 | 25,000 | 65,500 | 263,000 | |
| Sep 10 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 21.01 | 20,000 | 420,200 | 310,815 | 330.8 K to 310.8 K (-6.05 %) |
| Sep 10 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 18.00 | 25,000 | 450,000 | 330,815 | 355.8 K to 330.8 K (-7.03 %) |
| Sep 10 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 4.75 | 20,000 | 95,000 | 355,815 | 335.8 K to 355.8 K (+5.96 %) |
| Sep 10 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.62 | 25,000 | 65,500 | 335,815 | 310.8 K to 335.8 K (+8.04 %) |
| Jun 20 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 20,000 | 40,200 | 288,000 | |
| Jun 20 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 14.01 | 20,000 | 280,200 | 310,815 | 330.8 K to 310.8 K (-6.05 %) |
| Jun 20 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 20,000 | 40,200 | 330,815 | 310.8 K to 330.8 K (+6.43 %) |
| Jun 20 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 20,000 | 40,200 | 288,000 | |
| Jun 20 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 14.01 | 20,000 | 280,200 | 310,815 | 330.8 K to 310.8 K (-6.05 %) |
| Jun 20 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 20,000 | 40,200 | 330,815 | 310.8 K to 330.8 K (+6.43 %) |
| Jun 01 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 12,600 | 25,326 | 308,000 | |
| Jun 01 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 1,400 | 2,814 | 320,600 | |
| Jun 01 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 11.00 | 12,600 | 138,600 | 310,815 | 323.4 K to 310.8 K (-3.90 %) |
| Jun 01 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 12,600 | 25,326 | 323,415 | 310.8 K to 323.4 K (+4.05 %) |
| Jun 01 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 11.00 | 1,400 | 15,400 | 310,815 | 312.2 K to 310.8 K (-0.45 %) |
| Jun 01 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 1,400 | 2,814 | 312,215 | 310.8 K to 312.2 K (+0.45 %) |
| Mar 27 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 20,000 | 40,200 | 322,000 | |
| Mar 27 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 8.00 | 20,000 | 160,000 | 310,815 | 330.8 K to 310.8 K (-6.05 %) |
| Mar 27 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 20,000 | 40,200 | 330,815 | 310.8 K to 330.8 K (+6.43 %) |
| Mar 05 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Payment of Exercise | F | 6.66 | 8,208 | 54,665 | 310,815 | 319 K to 310.8 K (-2.57 %) |
| Jan 03 2018 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 319,023 | 244 K to 319 K (+30.73 %) |
| Jan 04 2017 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Grant | A | 0.00 | 145,000 | 0 | 260,689 | 115.7 K to 260.7 K (+125.34 %) |
| Aug 24 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 6,900 | 13,869 | 342,000 | |
| Aug 24 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 2.01 | 13,100 | 26,331 | 348,900 | |
| Aug 24 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 8.00 | 6,900 | 55,200 | 115,689 | 122.6 K to 115.7 K (-5.63 %) |
| Aug 24 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 6,900 | 13,869 | 122,589 | 115.7 K to 122.6 K (+5.96 %) |
| Aug 24 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 8.00 | 13,100 | 104,800 | 115,689 | 128.8 K to 115.7 K (-10.17 %) |
| Aug 24 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 2.01 | 13,100 | 26,331 | 128,789 | 115.7 K to 128.8 K (+11.32 %) |
| Mar 08 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Payment of Exercise | F | 4.33 | 6,263 | 27,119 | 115,689 | 122 K to 115.7 K (-5.14 %) |
| Feb 09 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Payment of Exercise | F | 3.46 | 13,048 | 45,146 | 121,952 | 135 K to 122 K (-9.67 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | A | 6.15 | 40,000 | 246,000 | 362,000 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 135,000 | 85 K to 135 K (+58.82 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 6.13 | 23,347 | 143,117 | 85,000 | 108.3 K to 85 K (-21.55 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Payment of Exercise | F | 6.13 | 13,153 | 80,628 | 108,347 | 121.5 K to 108.3 K (-10.83 %) |
| Mar 06 2015 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 7.75 | 50,000 | 387,500 | 322,000 | |
| Mar 06 2015 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Grant | A | 0.00 | 50,000 | 0 | 121,500 | 71.5 K to 121.5 K (+69.93 %) |
| Aug 30 2010 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Buy | P | 0.89 | 15,000 | 13,350 | 15,000 | 0 to 15 K |
| Aug 17 2010 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 0.99 | 120,000 | 118,800 | 450,000 |
Page: 1